Literature DB >> 15118855

New cell lines with chondrocytic phenotypes from human chondrosarcoma.

Ikuo Kudawara1, Nobuhito Araki, Akira Myoui, Yoichi Kato, Atsumasa Uchida, Hideki Yoshikawa.   

Abstract

In the present study, we investigated chondrocytic characterization for newly established human chondrosarcoma cell lines. A chondrosarcoma cell line, HCS-TG, was established by the implantation of grade-2 human chondrosarcoma into athymic mice. Cloning of HCS-TG cells from passage 17 was performed. After cell cloning, two clonal-cell lines (HCS-TG C3 and E2) with good proliferative activities were obtained. These cell lines in monolayer culture retained a polygonal morphology. Their doubling times were 68 h and 45 h, respectively. mRNA expressions of type-I, -II, -X, and -XI collagens and aggrecan core protein were detected on reverse-transcription polymerase chain reaction. Protein expression of type-II collagen was confirmed in each cell line using Western blotting. However, there was no expression of type-I collagen. Moreover, gelatin zymography revealed that both cell lines produced extracellular matrices with matrix metalloproteinases 2 and 9. The parental HCS-TG cells had tumorigenicity in athymic mice; however, C3 and E2 were not tumorigenic. New clonal-cell lines HCS-TG C3 and E2 derived from human chondrosarcoma are morphologically chondrocytic in serial monolayer cultures and express chondrocytic phenotypes. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15118855     DOI: 10.1007/s00428-004-1020-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  45 in total

1.  Chromosome rearrangements at 12q13 in two cases of chondrosarcomas.

Authors:  Y Hirabayashi; M A Yoshida; T Ikeuchi; T Ishida; T Kojima; S Higaki; R Machinami; A Tonomura
Journal:  Cancer Genet Cytogenet       Date:  1992-05

2.  Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading.

Authors:  H L Evans; A G Ayala; M M Romsdahl
Journal:  Cancer       Date:  1977-08       Impact factor: 6.860

Review 3.  The collagens: an overview and update.

Authors:  E J Miller; S Gay
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas.

Authors:  Thomas Aigner; Susanna Müller; Daniel Neureiter; Duane M Illstrup; Thomas Kirchner; Johannes Björnsson
Journal:  Cancer       Date:  2002-04-15       Impact factor: 6.860

5.  The biology of human chondrosarcoma. II. Variation in chemical composition among types and subtypes of benign and malignant cartilage tumors.

Authors:  H J Mankin; K P Cantley; A L Schiller; L Lippiello
Journal:  J Bone Joint Surg Am       Date:  1980-03       Impact factor: 5.284

6.  Synthesis of chondrocytic keratan sulphate-containing proteoglycans by human chondrosarcoma cells in long-term cell culture.

Authors:  J A Block; S E Inerot; S Gitelis; J H Kimura
Journal:  J Bone Joint Surg Am       Date:  1991-06       Impact factor: 5.284

7.  Immunohistological study on collagenous proteins of benign and malignant human cartilaginous tumours of bone.

Authors:  Y Ueda; Y Oda; H Tsuchiya; K Tomita; I Nakanishi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

8.  Immunohistochemical localization of collagenous proteins in cartilaginous tumors: characteristic distribution of type IX collagen.

Authors:  A Kawashima; Y Ueda; H Tsuchiya; K Tomita; Y Nagai; I Nakanishi
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Immunohistochemical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage.

Authors:  K Okajima; I Honda; T Kitagawa
Journal:  Cancer       Date:  1988-02-15       Impact factor: 6.860

10.  Complex cytogenetic aberrations in a well-differentiated chondrosarcoma.

Authors:  J A Fletcher; K K Lipinski; N Weidner; C C Morton
Journal:  Cancer Genet Cytogenet       Date:  1989-08
View more
  4 in total

1.  New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis.

Authors:  Jonathan Cm Clark; Toru Akiyama; Crispin R Dass; Peter Fm Choong
Journal:  Cancer Cell Int       Date:  2010-06-28       Impact factor: 5.722

2.  Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2.

Authors:  Xiaoyang Li; Dylan C Dean; Al Ferreira; Scott D Nelson; Francis J Hornicek; Shengji Yu; Zhenfeng Duan
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

3.  Establishment of novel human dedifferentiated chondrosarcoma cell line with osteoblastic differentiation.

Authors:  Naoko Kudo; Akira Ogose; Tetsuo Hotta; Hiroyuki Kawashima; Wenguang Gu; Hajime Umezu; Tsuyoshi Toyama; Naoto Endo
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.535

4.  Chondrosarcoma and peroxisome proliferator-activated receptor.

Authors:  K Nishida; T Kunisada; Z N Shen; Y Kadota; K Hashizume; T Ozaki
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.